{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T11:54:36Z","timestamp":1777290876953,"version":"3.51.4"},"reference-count":16,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2023,1,13]]},"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:p>Vitamin D deficiency is relatively common, and its management in patients with sarcoidosis is challenging due to the risk of hypercalcaemia. Our patient had an autologous stem cell transplant for multiple sclerosis and was given high-dose vitamin D concurrently with immunosuppressive therapy. The patient subsequently presented with symptomatic hypercalcaemia and an acute kidney injury. A clinical and biochemical recovery was reached by withdrawing vitamin D and administering intravenous fluids. Interestingly, new evidence suggests that activated vitamin D can actually dampen the inflammatory process in sarcoidosis, and this was reflected in a reduction of our patient\u2019s serological markers of sarcoidosis activity. One large study found no significant risk of hypercalcaemia when low doses of vitamin D were used in sarcoidosis. Where indicated, and until clear guidelines are established, we suggest using low doses of vitamin D with cautious monitoring of calcium and renal function.<\/jats:p>","DOI":"10.1136\/bcr-2022-250580","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T10:10:11Z","timestamp":1674468611000},"page":"e250580","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Vitamin D-induced hypercalcaemia and acute kidney injury in sarcoidosis"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5656-3599","authenticated-orcid":false,"given":"Dominic","family":"Doyle","sequence":"first","affiliation":[{"name":"Respiratory, Cork University Hospital, Cork, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Una","family":"Browne","sequence":"additional","affiliation":[{"name":"Respiratory, Cork University Hospital, Cork, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Brickley","sequence":"additional","affiliation":[{"name":"Respiratory, Cork University Hospital, Cork, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desmond","family":"Murphy","sequence":"additional","affiliation":[{"name":"Respiratory, Cork University Hospital, Cork, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,1,23]]},"reference":[{"key":"2025082709183856000_16.1.e250580.1","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s00198-017-3962-y","article-title":"Risk of fragility fracture among patients with sarcoidosis: a population-based study 1976-2013","volume":"28","author":"Ungprasert","year":"2017","journal-title":"Osteoporos Int"},{"key":"2025082709183856000_16.1.e250580.2","first-page":"1959","article-title":"A practical approach to hypercalcemia","volume":"67","author":"Carroll","year":"2003","journal-title":"Am Fam Physician"},{"key":"2025082709183856000_16.1.e250580.3","doi-asserted-by":"crossref","unstructured":"Lemke D , Klement RJ , Schweiger F , et al . Vitamin D resistance as a possible cause of autoimmune diseases: a hypothesis confirmed by a therapeutic high-dose vitamin D protocol. Front Immunol 2021;12 doi:10.3389\/fimmu.2021.655739","DOI":"10.3389\/fimmu.2021.655739"},{"key":"2025082709183856000_16.1.e250580.4","doi-asserted-by":"crossref","first-page":"e555","DOI":"10.1016\/j.amjmed.2021.04.037","article-title":"An uncommon cause of severe hypercalcemia: vitamin D supplementation in sarcoidosis","volume":"134","author":"Thapa","year":"2021","journal-title":"Am J Med"},{"key":"2025082709183856000_16.1.e250580.5","first-page":"1778","article-title":"Hypercalcemia in sarcoidosis","volume":"60","author":"Katakami","year":"2002","journal-title":"Nihon Rinsho"},{"key":"2025082709183856000_16.1.e250580.6","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.7.707"},{"key":"2025082709183856000_16.1.e250580.7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43162-021-00067-8","article-title":"Incidence, etiology, and course of hypercalcemia-induced AKI in a tertiary care center from northern india","volume":"33","author":"Bhat","year":"2021","journal-title":"Egypt J Intern Med"},{"key":"2025082709183856000_16.1.e250580.8","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/69.5.842"},{"key":"2025082709183856000_16.1.e250580.9","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/acr.20295","article-title":"American College of rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"62","author":"Grossman","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025082709183856000_16.1.e250580.10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4158\/EP161608.CR","article-title":"Protection of bone density in sarcoidosis: can we give vitamin D without causing hypercalcemia?","volume":"3","author":"Robertson","year":"2017","journal-title":"AACE Clinical Case Reports"},{"key":"2025082709183856000_16.1.e250580.11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.33176\/AACB-20-00006","article-title":"Vitamin D metabolism and guidelines for vitamin D supplementation","volume":"41","author":"Ramasamy","year":"2020","journal-title":"Clin Biochem Rev"},{"key":"2025082709183856000_16.1.e250580.12","first-page":"113","article-title":"Calcium and vitamin D metabolism in sarcoidosis","volume":"30","author":"Baughman","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2025082709183856000_16.1.e250580.13","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1055\/s-0040-1713009","article-title":"Balancing altered calcium metabolism with bone health in sarcoidosis","volume":"41","author":"Zhou","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"key":"2025082709183856000_16.1.e250580.14","doi-asserted-by":"crossref","unstructured":"Filipovic S , Violeta V , Jelica V , et al . Vitamin D deficiency and activity of sarcoidosis. ERS International Congress 2016 abstracts; September 2016:827. doi:10.1183\/13993003.congress-2016.PA827","DOI":"10.1183\/13993003.congress-2016.PA827"},{"key":"2025082709183856000_16.1.e250580.15","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1002\/jbmr.2262","article-title":"Calcium and vitamin D in sarcoidosis: is supplementation safe?","volume":"29","author":"Kamphuis","year":"2014","journal-title":"J Bone Miner Res"},{"key":"2025082709183856000_16.1.e250580.16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.12703\/b\/9-14","article-title":"The role of vitamin D in sarcoidosis","volume":"9","author":"Gianella","year":"2020","journal-title":"Fac Rev"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2022-250580","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T16:18:50Z","timestamp":1756311530000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2022-250580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,23]]},"published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1136\/bcr-2022-250580"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2022-250580","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]}}}